CA9 and neoplasm: Therefore, a histopathological examination of the patient’s tumor or other procedures, such as PET imaging [72,73], are necessary in order to deduce if therapy with a CAIX/XII inhibitor such as SLC-0111 will be beneficial for the patient due to high expression of CAIX and/or CAXII.